Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177Lu) chloride, Date of authorisation: 06/07/2016, Revision: 11, Status: Authorised

Timetable: Initial (full) marketing authorisation application accelerated assessment timetables - Advanced therapy medicinal product (ATMP)

Timetable: Initial (full) marketing authorisation application accelerated assessment timetables

Timetable: Initial (Full) marketing authorisation application - ATMP

Timetable: Informed consent and multiple application

Timetable: Extension application

Timetable: Accelerated assessment request for initial marketing authorisations - ATMP

Timetable accelerated assessment request for initial marketing authorisation applications